ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Anti-Smoking Resolution Lost In White House; Pay Bill Defeat Leaves 73 At The Top In NCI

March 22, 1974

Study: Robotic-Assisted Surgery Offers Better Cancer Control

March 28, 2014

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

June 15, 2007

In Brief: Diagnostic Imaging Cost Declines By Half as Percentage Of Health Cost In 10 Years

January 11, 1985

Firm’s Information System Embedded In iKnowMed For Treatment Outcomes.

June 29, 2001

White House Proposes NCI Budget Cut Of $40 Million or FY2007; NIH Budget Flat. Cuts And Earmarks Threaten To Derail 2015 Goal, NCI Director Says; “We Are In Difficult Times.”

February 10, 2006